Studies on cellular and humoral immunity elicited by influenza A virus infection and vaccination
Iowa Research Online (The University of Iowa) · 22.07.2024
DOI: 10.25820/etd.007702 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iowa Research Online (The University of Iowa), erschienen am 22.07.2024. Verfasst von Christopher E. Lopez.
Abstract (Originalsprache)
Influenza A virus (IAV) infections represent a serious public health threat and account for significant morbidity and mortality worldwide due to seasonal epidemics and periodic pandemics. Prevention and control of IAV infection is dependent on the host immune response, particularly the adaptive immune response which can be greatly aided through prior IAV exposure via infection or vaccination. While vaccination represents an important and efficacious countermeasure to combat IAV, present vaccines predominately provide protection against matched strains of IAV, generate little heterosubtypic protection against distinct unrelated IAV strains and are subject to antigen mismatch due to the continuous antigenic drift/shift of circulating strains. As a result, the IAV field has focused on the development of a universal IAV vaccine capable of providing long-term robust protection against multiple strains of IAV. Previously my laboratory has reported on a novel intranasally administered biocompatible polyanhydride [copolymers of 1,8-bis(p-carboxyphenoxy)-3,6-dioxoctane (CPTEG) and 1,6-bis(p-carboxyphenoxy)hexane (CPH)] nanoparticle-based vaccine platform (IAV-nanovax) capable of inducing robust cellular and humoral immune responses resulting in protection against subsequent homologous and heterosubtypic IAV infections in both inbred and outbred populations of mice. However, using the IAV-nanovax platform to incorporate disparate antigens from different stains of IAV leading to immunity and protection has not been examined yet as our initial report utilized IAV-nanovax encapsulating hemagglutinin (HA) and nucleoprotein (NP) derived from an H1N1 strain (A/Puerto Rico/8/1934) (H1-nanovax).
Schlagwörter
Zitieren
APA
Lopez, C. E. (2024). Studies on cellular and humoral immunity elicited by influenza A virus infection and vaccination. Iowa Research Online (The University of Iowa). https://doi.org/10.25820/etd.007702
Vancouver
Lopez CE. Studies on cellular and humoral immunity elicited by influenza A virus infection and vaccination. Iowa Research Online (The University of Iowa). 2024. doi:10.25820/etd.007702
BibTeX
@article{Lopez2024,
author = {Lopez, Christopher E.},
title = {Studies on cellular and humoral immunity elicited by influenza A virus infection and vaccination},
journal = {Iowa Research Online (The University of Iowa)},
year = {2024},
doi = {10.25820/etd.007702}
}
EUVIMED